Verapamil recalls

The FDA has published 8 recalls involving Verapamil since 2013. The latest was reported on 17 Jul 2024. Most were for potency & assay. Amerisource Health Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls8since 2013
Last 12 months0reported
Class I00% of total
Ongoing2latest 17 Jul 2024

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 5 63%Class III 3 38%

By year

Ongoing verapamil recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIVerapamil Hydrochloride Injection, USP 10 mg/ 5 mg/mL) recalledVerapamil HydrochlorideZydus Pharmaceuticals (USA)OtherNationwide
DrugCLASS IIIVerapamil Hydrochloride Injection, USP 5 mg /(2.5 mg/mL) recalledVerapamil HydrochlorideZydus Pharmaceuticals (USA)Packaging DefectsNationwide

All verapamil recalls, newest first

8 total

Should you stop taking Verapamil?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.